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Background: Apolipoprotein (apo)B is the structural apoprotein of intestinally- and liver- derived lipoproteins and
plays an important role in the transport of triacylglycerol (TAG) and cholesterol. Previous studies have examined the
association between the APOB insertion/deletion (ins/del) polymorphism (rs17240441) and postprandial lipaemia in
response to a single meal; however the findings have been inconsistent with studies often underpowered to
detect genotype-lipaemia associations, focused mainly on men, or with limited postprandial characterisation
of participants. In the present study, using a novel sequential test meal protocol which more closely mimics
habitual eating patterns, we investigated the impact of APOB ins/del polymorphism on postprandial TAG,
non-esterified fatty acids, glucose and insulin levels in healthy adults.
Findings: Healthy participants (n = 147) consumed a standard test breakfast (0 min; 49 g fat) and lunch
(330 min; 29 g fat), with blood samples collected before (fasting) and on 11 subsequent occasions until
480 min after the test breakfast. The ins/ins homozygotes had higher fasting total cholesterol, LDL-cholesterol,
TAG, insulin and HOMA-IR and lower HDL-cholesterol than del/del homozygotes (P < 0.017). A higher area
under the time response curve (AUC) was evident for the postprandial TAG (P < 0.001) and insulin (P = 0.032)
responses in the ins/ins homozygotes relative to the del/del homozygotes, where the genotype explained
35% and 7% of the variation in the TAG and insulin AUCs, respectively.
Conclusions: In summary, our findings indicate that the APOB ins/del polymorphism is likely to be an important
genetic determinant of the large inter-individual variability in the postprandial TAG and insulin responses to
dietary fat intake.
Keywords: APOB gene, Signal peptide polymorphism, Insertion/deletion polymorphism, Postprandial study,
Sequential test meals, TriacylglycerolFindings
Introduction
Apolipoprotein (Apo)B is the structural apoprotein of
intestinally- (e.g. chylomicrons, apoB-48) and liver- (e.g. very
low density lipoprotein (VLDL), apoB-100) derived lipopro-
teins and plays an important role in the transport of triacyl-
glycerol (TAG) and cholesterol [1]. The APOB insertion/* Correspondence: v.karani@reading.ac.uk
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unless otherwise stated.deletion (ins/del) polymorphism (rs17240441), which pro-
duces a difference of three amino acids in the signal pep-
tide, has been associated with fasting total cholesterol
(TC) [2,3], TAG [4,5], high density lipoprotein-cholesterol
(HDL-C) [2] and low density lipoprotein-cholesterol (LDL-C)
[2,3] concentrations, along with cardiovascular disease-
related outcomes [6-11]. In addition, the effect of this
polymorphism on lipid metabolism appears to be modu-
lated by dietary fat and cholesterol intakes [4,12].
Non-fasting (postprandial) TAG is now recognised as a
highly significant and arguably independent risk factor for
cardiovascular disease [13-16]. However, the postprandialentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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individual variability in response to meal ingestion shown
to be modulated by environmental and genetic factors
[13,14,17]. Previous studies have examined the association
between the APOB ins/del polymorphism and postpran-
dial lipaemia in response to a single meal [8,9,18,19] but
findings have been inconsistent with studies often under-
powered to examine genotype-lipaemia associations, fo-
cussed mainly on men, or with limited (both in terms of
time-points and measurements) postprandial characterisa-
tion of participants. Hence, in the present study, using a
novel sequential test meal protocol which more closely
mimics habitual eating patterns, we examined the effect of
the APOB ins/del polymorphism on postprandial TAG,
non-esterified fatty acids (NEFA), glucose and insulin levels
in healthy adults.
Methods
Study participants
The study was performed using postprandial data from
147 healthy participants who underwent the same sequen-
tial test meal protocol and similar inclusion/exclusion cri-
teria, at the University of Reading between 1997 and 2007,
as previously described [20]. Briefly, healthy men and
women aged 20-70 years, with a body mass index (BMI)
between 19-32 kg/m2, fasting TAG levels ≤4 mmol/l and
total cholesterol ≤8 mmol/l were recruited (Table 1). The
studies were approved by the University of Reading
Research Ethics Committee and the West Berkshire
Health Authority Ethics Committee, and written in-
formed consent was obtained from all participants.Table 1 Characteristics of the men and women in the
postprandial dataset (n = 147)
Men Women P value
Age (y) 54 ± 10 54 ± 11 0.868
BMI (kg/m2) 27.6 ± 3.1 25.6 ± 3.5 0.002
TC (mmol/l) 6.15 ± 0.94 5.99 ± 0.97 0.390
TAG (mmol/l) 2.05 ± 0.83 1.39 ± 0.50 <0.001
HDL-C (mmol/l) 1.10 ± 0.26 1.41 ± 0.27 <0.001
LDL-C (mmol/l) 4.12 ± 0.91 3.95 ± 0.81 0.313
NEFA (μmol/l) 490 ± 185 539 ± 202 0.288
Glucose (mmol/l) 5.32 ± 0.67 5.14 ± 0.48 0.109
Insulin (pmol/l) 54.0 ± 32.0 39.2 ± 26.3 0.011
HOMA-IR 2.2 ± 1.5 1.5 ± 1.1 0.010
Values represent mean ± SD for n = 112 men and n = 35 women.
The data represents n = 85 men and n = 34 women for insulin and HOMA-IR,
and n = 109 men and n = 33 women for NEFA.
Abbreviations: BMI body mass index, NEFA non-esterified fatty acids, LDL-C low
density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol,
HOMA-IR homeostasis model assessment of insulin resistance, TAG triacylglycerol,
TC total cholesterol.Postprandial protocol
Details of the postprandial protocol have been described
previously [20]. Briefly, study participants were asked to
refrain from alcohol or organised exercise regimens on
the previous day and were provided with a relatively low
fat (<10 g fat) evening meal to standardise short-term fat
intake. After a 12 h overnight fast, a blood sample was
taken. Following a standard test breakfast (0 min; 3.9 MJ
energy, 111 g carbohydrate, 19 g protein and 49 g fat) and
lunch (330 min; 2.3 MJ energy, 63 g carbohydrate, 15 g
protein and 29 g fat), blood samples were taken at 30–
60 min intervals until 480 min after the test breakfast.
Biochemical analysis
Plasma lipids and glucose were analysed with an auto-
mated analyser (Instrumentation Laboratory (UK) Ltd,
Warrington, UK) using enzyme-based kits supplied by
Instrumentation Laboratory and Alpha Laboratories
(Eastleigh, UK). In the fasting sample, HDL-C was mea-
sured in the supernatant following precipitation of the
apoB-containing lipoproteins with a dextran-manganese
chloride reagent. LDL-C was calculated using the Friedewald
formula. Insulin was measured by ELISA (Dako Ltd, High
Wycombe, UK). The homeostasis assessment model of
insulin resistance (HOMA-IR) was calculated using the for-
mula: [fasting insulin (pmol/l) × fasting glucose (mmol/l)]/
135. All samples for each individual were analysed within
a single batch and the inter-assay coefficient of variation
for the assays were less than 5%.
Genotyping
DNA was isolated from the buffy coat layer as previously
described [20]. The ins/del polymorphism was detected
using a PCR-agarose gel electrophoresis as described
previously [4]. The genotype distribution of this poly-
morphism was in concordance with Hardy-Weinberg
equilibrium (P = 0.87).
Statistical analysis
Statistical analysis was carried out using the STATA ver-
sion 13. The data were checked for normality prior to
statistical analysis and transformed where necessary. The
data in Table 1 which could not be normalised (age,
BMI, fasting total cholesterol, glucose, insulin, NEFA
and HOMA-IR) were analysed using a Mann-Whitney
test and an Independent-Samples t test for those with a
normal distribution. Postprandial summary measures for
the TAG, glucose and insulin responses included area
under the curve (AUC, 0-480 min) and incremental
AUC (IAUC, 0-480 min). Since postprandial NEFA con-
centrations show an initial drop after the breakfast meal,
NEFA AUC and IAUC responses were calculated from
the minimum concentration until the end of the post-
prandial investigation (120-480 min). Linear regression
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determine the impact of genotype on the fasting metab-
olites and postprandial summary measures (AUC and
IAUC). The interactions of the polymorphism with age,
gender and BMI were tested by including the interaction
term in the linear regression model.
Results
Table 1 shows the characteristics of the men and women
in the postprandial cohort. Men had significantly higher
BMI, fasting TAG, insulin and HOMA-IR, and lower
HDL-C than women (P ≤ 0.010).Table 2 Fasting metabolites and postprandial measures accor
study participants
Participant characteristics Del/Del
(n = 52)
Age (y) 52 ± 2
Gender (men/women) 36/16
Body mass index (kg/m2) 26.6 ± 0.4
Fasting metabolites
Total cholesterol (mmol/l) 5.77 ± 0.12A
Triacylglycerol (mmol/l) 1.62 ± 0.09A
LDL-C (mmol/l) 3.75 ± 0.10A
HDL-C (mmol/l) 1.29 ± 0.04A
NEFA (μmol/l) 525.4 ± 31.5
Glucose (mmol/l) 5.23 ± 0.08
Insulin∞ (pmol/l) 43.9 ± 3.37A
HOMA-IR 1.73 ± 0.14A
Postprandial summary measures
Triacylglycerol (mmol/l × 480 min)
AUC 1024.3 ± 52.5A
IAUC 273.3 ± 22.4A
NEFA (mmol/l × 300 min)¥
AUC 160.0 ± 5.8
IAUC 94.8 ± 7.3
Glucose (mmol/l × 480 min)
AUC 2979.1 ± 48.9
IAUC 489.9 ± 43.9
Insulin∞ (nmol/l × 480 min)
AUC 25.7 ± 8.6A
IAUC 113.2 ± 21.5
Values represent mean ± SEM. Abbreviations: AUC area under the curve, HDL-C high
insulin resistance, IAUC incremental area under the curve, LDL-C low density lipopro
Means with different superscript capital letters (A,B,C) denote significant differences
exact P values).
∞Only 119 individuals had data for fasting insulin (n = 52 for del/del, n = 53 for del/
(n = 10 for del/del, n = 15 for del/ins and n = 10 for ins/ins).
*Adjusted for age, gender and BMI.
**Adjusted for age and gender.
¥AUC and IAUC for the NEFA response are calculated from the time of suppressionCompared with the del/del homozygotes, insertion allele
carriers had higher fasting TC (versus ins/del P = 0.017;
ins/ins, P = 0.013), LDL-C (versus ins/del P = 0.011; ins/
ins, P = 0.017), TAG (versus ins/del, P = 0.049; ins/ins, P =
0.006), and lower HDL-C (versus ins/del, P = 0.004; ins/
ins, P = 0.003). Ins/Ins homozygotes had higher fasting in-
sulin and HOMA-IR than the del/del (P = 0.001) and ins/
del (P = 0.012) groups (Table 2). There was no association
between the polymorphism and fasting NEFA or glucose
concentrations (P > 0.079).
There was a significant effect of the APOB polymorph-
ism on the postprandial TAG response (Figure 1A), withding to the APOB insertion/deletion polymorphism in the
Ins/Del
(n = 70)
Ins/Ins
(n = 25)
Overall
P value*
56 ± 1 53 ± 2 0.176
53/17 23/2 0.090
27.2 ± 0.4 27.9 ± 0.8 0.184**
6.26 ± 0.11B 6.43 ± 0.21B 0.004
1.96 ± 0.10B 2.25 ± 0.14B 0.007
4.24 ± 0.11B 4.32 ± 0.19B 0.007
1.13 ± 0.03B 1.04 ± 0.04B 0.002
503.5 ± 22.2 448.0 ± 22.1 0.079
5.28 ± 0.07 5.39 ± 0.15 0.798
48.9 ± 4.08A 74.9 ± 12.3B 0.007
1.99 ± 0.18A 3.15 ± 0.57B 0.004
1268.9 ± 61.3B 1841.6 ± 135.4C <0.001
326.0 ± 25.4A 511.6 ± 58.3B <0.001
153.4 ± 6.2 149.8 ± 6.3 0.153
101.7 ± 3.9 91.3 ± 5.2 0.539
2946.9 ± 83.9 3184.9 ± 62.4 0.527
557.7 ± 31.4 533.3 ± 34.7 0.306
24.8 ± 6.1A 81.5 ± 23.0B 0.036
91.2 ± 9.8 172.8 ± 25.4 0.108
density lipoprotein cholesterol, HOMA-IR homeostasis model assessment of
tein cholesterol, NEFA non-esterified fatty acids.
between the Del/Del, Del/Ins and Ins/Ins genotypes (P < 0.05; see text for
ins and n = 14 for ins/ins) and n = 35 with postprandial insulin concentrations
(120 min) to the end of the postprandial period (480 min).
Figure 1 Effect of APOB ins/del polymorphism on postprandial
triacylglycerol (TAG) and insulin response. A. Mean (SEM) for
the postprandial TAG response in the APOB del/del (n = 52, open
circles), del/ins (n = 70, open squares) and ins/ins (n = 25, open
triangles) genotype groups after consumption of a test breakfast
(49 g fat) at 0 min and a test lunch (29 g fat) at 330 min. There was
a 44% and 31% higher TAG area under the curve (AUC) (del/del vs
ins/del, P = 0.010; del/del vs ins/ins, P < 0.001; ins/del vs ins/ins,
P < 0.001) in the ins/ins than del/del homozygotes and ins/del
heterozygotes, respectively. B. Mean (SEM) for the AUC for the
postprandial TAG response in men and women in the APOB del/del
(white bars; n = 36 men/n = 16 women), del/ins (black bars; n = 51
men/n = 17 women) and ins/ins (dotted bars; n = 23 men/n = 2
women) genotype groups. There was a significant effect of
genotype on the TAG AUC in men only (P = 0.043, del/del vs ins/del;
P < 0.001, ins/ins vs both del/del and ins/del) whereas differences
between genotypes were not evident in women (P > 0.501). C. Mean
(SEM) for the postprandial insulin response in the APOB del/del (n = 10,
open circles), del/ins (n = 15, open squares) and ins/ins (n = 10, open
triangles) genotype groups after consumption of a test breakfast
(49 g fat) at 0 min and a test lunch (29 g fat) at 330 min. There
was a 69% higher AUC in the ins/ins than ins/del (P = 0.004) and
del/del (P = 0.032) groups.
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0.010; del/del vs ins/ins, P < 0.001; ins/del vs ins/ins, P <
0.001) and 47% and 36% higher IAUC (del/del vs ins/ins,
P < 0.001; ins/del vs ins/ins, P = 0.001) in the ins/ins than
del/del homozygotes and ins/del heterozygotes, respect-
ively (Table 2). The polymorphism explained 35% and
20% of the variation in the TAG AUC and IAUC, re-
spectively. The penetrance of genotype on TAG AUC
and IAUC did not vary by age (P > 0.94) or BMI (P > 0.10);
however, there was a significant interaction with gender
(P < 0.04), with an impact of genotype observed only in
men. Even after excluding the ins/ins individuals (n = 25),
given the gender imbalance in this group (Table 2), a
gender-specific effect of genotype on postprandial TAG
AUC was still observed (men, P = 0.01; women, P = 0.24)
(Figure 1B).
For the postprandial insulin response (Figure 1C), a
significant effect of the polymorphism on AUC but not
IAUC (P = 0.108) was observed, with a 69% higher AUC
in the ins/ins than ins/del (P = 0.004) and del/del (P =
0.032) groups. The genotype explained 7% of the vari-
ation in AUC. Significant genotype effects were not ob-
served for the summary measures of the postprandial
glucose and NEFA responses.
Discussion
Our data provides evidence of a significant role of the
APOB ins/del polymorphism in determining postprandial
TAG and insulin responses to sequential meal ingestion.
Furthermore, we have shown an impact of this polymorph-
ism on the fasting lipid profile, insulin and HOMA-IR, a
surrogate measure of insulin resistance.
Vimaleswaran et al. Nutrition & Metabolism  (2015) 12:7 Page 5 of 6The ins/del polymorphism arises due to an insertion
or a deletion of 9 base pairs that produces apoB signal
peptides of 27 and 24 amino acids in length, respectively
[21]. A less effective translocation of newly synthesised
apoB across the endoplasmic reticulum membrane has
been reported with the shorter signal peptide, suggesting
this polymorphism may impact on TAG-rich lipoprotein
(TRL, CM and VLDL) production. As with previous find-
ings [8,9,19], insertion allele carriers showed higher fasting
and postprandial TAG concentrations which was associ-
ated with decreased HDL-C levels. Intriguingly, the dose
response for the impact of the insertion allele on TAG-
AUC (ins/ins > ins/del > del/del) was only evident in men,
a phenomenon we have previously observed in our cohort
for the LEPR [20] and APOA5 [22] genotypes. Expression
of the biochemical phenotype of this APOB polymorph-
ism has been proposed to be dependent on the popu-
lation studied [19]. Irrespective of genotype, men had
higher BMI, fasting TAG, insulin and HOMA-IR, and
lower HDL-C than women (Table 1), which may have in-
fluenced the genotype-gender relationships with post-
prandial TAG handling. However, the small proportion of
women in our dataset (n = 35/147) limits definite conclu-
sions that the impact of genotype is only evident in men.
Dietary fat quantity has been reported to influence the
effect of this genotype on TAG levels, with a greater as-
sociation observed when participants consumed a high-
fat than low-fat diet. Xu et al. [4] proposed the overall
reduction in TRL synthesis during the low-fat diet to be
responsible for the loss of the genotype effect on the
intracellular handling of apoB. Furthermore, the TRL-
TAG content, but not particle number (apoB concentra-
tion), was different between the ins/del groups during
the high-fat diet indicating this polymorphism may also
influence TRL composition. The reduced ability of the
ins/ins homozygotes to handle dietary TAG after meal
ingestion in the present study was associated with a
higher fasting HOMA-IR and postprandial insulin AUC.
In the absence of any known direct effect of apoB on in-
sulin production or cellular action, it is likely that the
higher insulin levels are in response to higher postpran-
dial TAG. The associated loss of insulin sensitivity would
likely impact on various stages of TRL metabolism.
However, we did not determine apoB in the present study
and hence it is difficult to discriminate between the poten-
tial contributions of increased TRL production versus im-
paired TAG clearance (both highly insulin dependent
processes), to the higher TAG response in the insertion al-
lele carriers.
In summary, our findings indicate the APOB ins/del
polymorphism is likely to be an important determinant
of the inter-individual variability in the postprandial
TAG and insulin responses to dietary fat intake. How-
ever, we were unable to replicate these findings due tothe lack of access to another postprandial cohort with
data on this polymorphism. Hence, replication is highly
warranted and, to determine in particular whether the
penetrance of genotype on the TAG response is gender-
specific. Further work is required to investigate the
impact of the APOB ins/del polymorphism on TRL me-
tabolism, and coronary heart disease risk.
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